Form 424B1 - Prospectus [Rule 424(b)(1)]

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form 424B1 - Prospectus [Rule 424(b)(1)]

Article too big to display. Click here to view on the SEC website

Vivos Therapeutics (NASDAQ:VVOS)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Vivos Therapeutics Charts.

Vivos Therapeutics (NASDAQ:VVOS)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Vivos Therapeutics Charts.

Vivos Therapeutics Inc News

Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
Monday 24 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.
Tuesday 18 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 11 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 424B1 - Prospectus [Rule 424(b)(1)]
Friday 31 January 2025 (1 month ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Thursday 30 January 2025 (1 month ago) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Wednesday 22 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 26 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Monday 23 December 2024 (2 months ago) • GlobeNewswire Inc.

More Vivos Therapeutics Inc News Articles

AMC Entertainment

Asia Broadband (PK)

Voip Pal Com (QB)

Bioelectronics (PK)

Intergrated Cannabis Sol... (PK)

NioCorp Developments

Digital Brand Media and ... (PK)

Lightwave Logic

Elite Pharmaceuticals (QB)

Good Vibrations Shoes (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions